Zhang L, Hsieh MC, Petkov V, Yu Q, et al. Trend and survival benefit of Oncotype DX use among female hormone receptor-positive breast cancer patients in 17 SEER registries, 2004-2015. Breast Cancer Res Treat 2020 Feb 14. pii: 10.1007/s10549-020-05557.
PMID: 32060781